TY  - GEN
AU  - Francis,C W
AU  - Kessler,C M
AU  - Goldhaber,S Z
AU  - Kovacs,M J
AU  - Monreal,M
AU  - Huisman,M V
AU  - Bergqvist,D
AU  - Turpie,A G
AU  - Ortel,T L
AU  - Spyropoulos,A C
AU  - Pabinger,I
AU  - Kakkar,A K
TI  - Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study
SN  - 1538-7836
PY  - 2016///0225
KW  - Aged
KW  - Anticoagulants
KW  - administration & dosage
KW  - Canada
KW  - Dalteparin
KW  - Drug Administration Schedule
KW  - Europe
KW  - Female
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - blood
KW  - Prospective Studies
KW  - Recurrence
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
KW  - Venous Thromboembolism
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/jth.12923
ER  -